F18.24 Inhalant dependence with inhalant-induced mood disorder

Name of the Condition

• Common Name: Inhalant Dependence with Inhalant-Induced Mood Disorder
• Medical Term: Inhalant Dependence with Inhalant-Induced Mood Disorder

Summary

Inhalant dependence with inhalant-induced mood disorder is a substance use disorder characterized by a problematic pattern of inhalant use leading to clinically significant impairment or distress, accompanied by a mood disorder directly resulting from inhalant use. This condition involves physiological, behavioral, and cognitive symptoms related to continued use despite adverse consequences, including tolerance, withdrawal, and compulsive use, while also presenting with mood-related symptoms such as depression or mania induced by the substance.

Causes

Inhalant dependence with inhalant-induced mood disorder develops from repeated misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects. Inhalants are often common household or industrial products, such as glue, paint thinners, aerosols, or solvents. Prolonged use can alter brain chemistry, leading to dependence and mood disturbances, as the substances disrupt neurotransmitter systems involved in mood regulation.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Withdrawal symptoms when use is reduced or stopped.
• Mood disorder symptoms (e.g., persistent sadness, irritability, or elevated mood) directly linked to inhalant use.

Diagnosis

Diagnosis involves a comprehensive evaluation of the patient's substance use history, behavioral patterns, and mood symptoms. Clinicians assess for a problematic pattern of inhalant use leading to impairment, along with mood disturbances that are temporally related to inhalant exposure. Physical exams and lab tests may rule out other causes, while diagnostic criteria for both inhalant dependence and inhalant-induced mood disorder are applied to confirm the condition.

Treatment Options

Treatment typically includes a combination of behavioral therapies, such as cognitive-behavioral therapy, to address dependence and mood symptoms. Medications may be used to manage withdrawal or co-occurring mood disorders, though specific pharmacological treatments for inhalant-induced mood disorders are limited. Supportive care, including counseling and peer support groups, is often integral to recovery.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, adherence to treatment, and presence of co-occurring conditions. With appropriate intervention, some individuals achieve sustained remission, though relapse is possible. Regular follow-up is essential to monitor mood symptoms, substance use, and overall functioning, adjusting treatment as needed to address ongoing challenges.

Complications

• Worsening of mood disorder symptoms, including depression or mania.
• Increased risk of overdose or accidental injury due to impaired coordination.
• Long-term cognitive impairment or organ damage from chronic inhalant use.
• Social or occupational dysfunction due to persistent substance use and mood disturbances.

Lifestyle & Prevention

• Avoiding exposure to inhalant substances and educating individuals on their risks.
• Seeking early intervention for substance use or mood-related concerns.
• Engaging in healthy coping mechanisms and stress-reduction strategies.
• Building a support network to reinforce abstinence and mental health stability.

When to Seek Professional Help

Seek professional help if inhalant use is causing mood changes, difficulty controlling use, or impairment in daily life. Immediate care is needed for severe withdrawal symptoms, suicidal thoughts, or signs of overdose.

Tips for Medical Coders

When coding F18.24, ensure documentation supports both inhalant dependence and the presence of an inhalant-induced mood disorder. Verify that the mood disorder is directly attributed to inhalant use, with clear temporal and clinical correlation. Document the severity, duration, and impact on functioning to justify the diagnosis and support accurate coding.